Quest Diagnostics

DGX · NYSE · USD

$233.33Change from previous close: +0.97%Absolute change: +$2.24

Close · October 2, 2026

At a glance

Revenue growth
+11.78%
2025 vs 2024
Net income growth
+13.89%
2025 vs 2024
Net margin
9.0%
2024: 8.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets16,22516,15314,02212,837—
Current assets2,3782,3922,3721,898—
Cash and equivalents420549686315—
Receivables1,4081,3041,2101,195—
Inventory189188190192—
Net property, plant and equipment2,8602,7642,4182,351—
Goodwill8,9458,8567,7337,220—
Other intangible assets1,6361,7631,1661,092—
Long-term investments136123135132—
Current liabilities2,2782,1691,8151,551—
Accounts payable307287378324—
Long-term debt5,1675,6154,4103,978—
Total debt6,5857,0875,4984,714—
Total liabilities8,9399,2577,6046,830—
Total equity (incl. minority)7,2866,8966,4186,007—
Retained earnings9,9949,3608,8258,290—
Minority interest116118111114—